Vivo Capital, LLC Valneva Se Transaction History

Vivo Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$27.1 - $67.28 $5.42 Million - $13.5 Million	-200,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.02 - $53.38 $5 Million - $10.7 Million	-200,000 Reduced 50.0%	200,000 $6.28 Million
Q2 2021 Aug 16, 2021	BUY	$24.41 - $31.04 $9.76 Million - $12.4 Million	400,000 New	400,000 $10.5 Million

718K

Ticker VALN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,103,504
Market Cap $263M
Description
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.